Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Because the bladder neck and proximal urethra contain abundant α1-adrenergic receptors,
α-blockers or α1-blockers are well-known to reduce bladder neck obstruction in patients with
or without neurogenic bladder.
α1-blockers seem to have a potential to reduce bladder outlet resistance during voiding in
patients with neurogenic bladder.
Based on these turnouts, we designed this clinical study to evaluate the clinical effect and
safety of silodosin on voiding dysfunction associated with neurogenic bladder.